Postponing implementation of OMB Federal Research Funding Restrictions
ARLINGTON, Va. (Sept. 1, 2026)– The American Diabetes Association® (ADA) applauds the passage of the Continuing Resolution (CR) by Congress which maintains current federal funding levels for critical diabetes research and prevention programs through December 11. The CR also postpones implementation of the Office of Management and Budget (OMB) Interim Final Rule (IFR) on federal grantmaking through the duration of the CR.
The CR ensures stable funding for National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK) at current levels of $2.3 billion and Centers for Disease Control and Prevention (CDC) Division of Diabetes Translation at $163 million, Division of Nutrition, Physical Activity and Obesity at $54.3 million and National Diabetes Prevention Program at $37.3 million. These agencies represent critical diabetes research and prevention funding across the U.S.
The ADA appreciates Congress protecting the current merit-based, peer-reviewed framework for federal research grantmaking by halting implementation of OMB proposed guidance.
Maintaining the current federal research funding provides essential continuity for researchers, public health agencies, academic institutions, and community-based programs that depend on predictable federal support. Biomedical research requires sustained investment and a grantmaking process grounded in scientific rigor, transparency, and clearly defined performance standards. Disruptions to that framework can delay research, weaken public health programs, and impede progress in preventing, treating, and curing diabetes.
ADA encourages Congress to pass funding for the rest of the 2027 fiscal year as soon as possible. Full-year funding reduces the uncertainty caused by government shutdowns and ensures sustainable funding for critical diabetes research and prevention programs.
The ADA also urges Congress to reject OMB’s wholesale revision of federal grantmaking and instead protect agencies’ science-based process for funding research and programs nationwide.
###
About the American Diabetes Association
The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to end diabetes and helping people thrive. For 86 years, the ADA has driven discovery and research to treat, manage, and prevent diabetes while working relentlessly for a cure. Through advocacy, program development, and education we work to improve the quality of life for the over 155 million Americans living with diabetes or prediabetes. To learn more or to get involved, visit us at diabetes.org or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn). To learn more about how we are advocating for everyone affected by diabetes, visit us on X (@AmDiabetesAssn).
